Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications - Wikidata - awgldk - TriplyDB

Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications

Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications

http://www.wikidata.org/entity/Q28079476

about

Low shear stress induces endothelial reactive oxygen species via the AT1R/eNOS/NO pathway.Role of endothelin-1 and its receptors, ETA and ETB, in the survival of human vascular endothelial cells.

P2860

Q46364121-5554AC8E-300F-4529-A9C4-FABA73778E1D Q51822328-11090724-2C35-4F10-8001-DD7E9ACFEA59

P2860

Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications

http://www.wikidata.org/entity/Q28079476

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Angiotensin receptor blockers ...... ion & therapeutic implications

@ast

Angiotensin receptor blockers ...... ion & therapeutic implications

@en

Angiotensin receptor blockers ...... ion & therapeutic implications

@nl

type

label

Angiotensin receptor blockers ...... ion & therapeutic implications

@ast

Angiotensin receptor blockers ...... ion & therapeutic implications

@en

Angiotensin receptor blockers ...... ion & therapeutic implications

@nl

prefLabel

Angiotensin receptor blockers ...... ion & therapeutic implications

@ast

Angiotensin receptor blockers ...... ion & therapeutic implications

@en

Angiotensin receptor blockers ...... ion & therapeutic implications

@nl

P1433

Q28079476-DCD2E470-9819-4606-B91D-A5B259D22780

P1476

Q28079476-FD1673CD-87E9-479E-81AD-4548CE100428

P2093

Q28079476-E2AC499E-2907-46F1-8715-2D1529EE584F

Q28079476-F0758323-5379-4BE2-AF11-3AE0624B8D1F

P275

Q28079476-CBD27548-95E2-40AC-807F-1B26B758D244

P2860

Q28079476-0766E287-8BD1-48B4-9D68-98422B6EFB76

Q28079476-084E8B4A-7D97-440F-913D-7116B363A1F0

Q28079476-0F5B381E-EFF6-44AB-A6F1-B65C6F7B09B1

Q28079476-1329EC40-A100-410C-9EA1-B7BBE024A56B

Q28079476-18B5CE0F-75C2-4A71-AAAB-DEFEED7BB3D5

Q28079476-19912C43-CB80-4954-BE2B-57235AACFA34

Q28079476-1AF71462-7FF1-44F8-9867-1AB125751A76

Q28079476-216C9A5E-F76E-46AB-97B9-4D6D7113FC86

Q28079476-34CF0752-8DB3-4CCE-8CA5-08DC1115AF8B

Q28079476-36BD58DE-0457-4D4C-84F7-B7667BF0A36C

P304

Q28079476-80365961-3D4E-4274-9D1C-5D49603E50DE

P31

Q28079476-911E2080-2094-410A-84CD-F54962A61C0C

P3181

Q28079476-4062CD4D-6721-4236-9093-BE0B193C89F6

P356

Q28079476-B9638DBB-59EF-4DEC-BBC6-50D2F4E37CD7

P407

Q28079476-E0DDA842-250E-47E9-A5BD-69AB97E3C6BF

P433

Q28079476-534E4DA4-F289-4CE5-B749-58A19B680916

P478

Q28079476-C1B2D89F-ACD8-472B-B663-EB68F7EF9A7A

P50

Q28079476-A2A5FE57-1186-44D5-8BC6-95C6C76F1B97

Q28079476-A6263A69-7B8F-4167-8EB5-39102521DD82

P5008

Q28079476-6DBD6B6F-DE75-496A-92C2-592D7743B81A

P577

Q28079476-A3202A6F-C749-4632-B3C1-916AD0B2F2AF

P698

Q28079476-A08D75D9-3F01-4D52-927B-226FBA3BDE9A

P921

Q28079476-67DB3425-F513-4B45-B395-F64A7990650D

Q28079476-EBA7C3D1-7516-4A76-81BA-911E81888B05

Q28079476-EBB55D68-9A9C-4119-9424-2C4B1EBF0782

P932

Q28079476-98D30BD8-8146-4C0D-B6F3-5B8188F6BABF

P3181

P356

0971-5916.195022

P1433

Indian Journal of Medical Research

P1476

Angiotensin receptor blockers ...... ion & therapeutic implications

@en

P2093

Ivana Milićević Nešić

http://www.w3.org/2001/XMLSchema#string

Milica Prostran

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Endothelial dysfunction: a comprehensive appraisal.

Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas

The physiological significance of the alternative pathways of angiotensin II production

Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.

Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation

Telmisartan prevents VCAM-1 induction and monocytic cell adhesion to endothelium exposed to non-uniform shear stress and TNF-α.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.

Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study.

P304

154-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4356975

http://www.w3.org/2001/XMLSchema#string

P356

10.4103/0971-5916.195022

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P50

Marko Stojanović

P5008

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27934794

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

mechanism of action

P932

5206866

http://www.w3.org/2001/XMLSchema#string